SG11202103026YA - Peptides for use in treating and preventing skin aging and photo-aging - Google Patents

Peptides for use in treating and preventing skin aging and photo-aging

Info

Publication number
SG11202103026YA
SG11202103026YA SG11202103026YA SG11202103026YA SG11202103026YA SG 11202103026Y A SG11202103026Y A SG 11202103026YA SG 11202103026Y A SG11202103026Y A SG 11202103026YA SG 11202103026Y A SG11202103026Y A SG 11202103026YA SG 11202103026Y A SG11202103026Y A SG 11202103026YA
Authority
SG
Singapore
Prior art keywords
aging
peptides
photo
treating
preventing skin
Prior art date
Application number
SG11202103026YA
Other languages
English (en)
Inventor
Pablo Pellegrini
Original Assignee
Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi filed Critical Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi
Publication of SG11202103026YA publication Critical patent/SG11202103026YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202103026YA 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging SG11202103026YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102018000009384A IT201800009384A1 (it) 2018-10-11 2018-10-11 Peptide for cosmetic application
PCT/IB2019/058641 WO2020075108A1 (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging

Publications (1)

Publication Number Publication Date
SG11202103026YA true SG11202103026YA (en) 2021-04-29

Family

ID=65010824

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103026YA SG11202103026YA (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging

Country Status (13)

Country Link
US (1) US20210395305A1 (ko)
EP (1) EP3863728A1 (ko)
JP (1) JP2022508676A (ko)
KR (1) KR20210075098A (ko)
CN (1) CN112823039A (ko)
AU (1) AU2019357261A1 (ko)
BR (1) BR112021006742A2 (ko)
CA (1) CA3115025A1 (ko)
EA (1) EA202190888A1 (ko)
IL (1) IL282064B (ko)
IT (1) IT201800009384A1 (ko)
SG (1) SG11202103026YA (ko)
WO (1) WO2020075108A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000020287A1 (it) * 2020-08-20 2022-02-20 Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi Peptide per applicazioni terapeutiche in campo dermatologico
KR20230046140A (ko) * 2021-09-29 2023-04-05 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR20230046141A (ko) * 2021-09-29 2023-04-05 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR20230046872A (ko) * 2021-09-30 2023-04-06 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR20230046873A (ko) * 2021-09-30 2023-04-06 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
GB9616105D0 (en) * 1996-07-31 1996-09-11 Univ Kingston TrkA binding site of NGF
EP0977860A1 (en) * 1997-04-25 2000-02-09 Genentech, Inc. Ngf variants
US6919426B2 (en) 2002-09-19 2005-07-19 Amgen Inc. Peptides and related molecules that modulate nerve growth factor activity
MEP31508A (en) 2003-07-15 2010-10-10 Amgen Inc Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
KR101520333B1 (ko) * 2008-11-25 2015-05-14 (주)아모레퍼시픽 글루타밀아미도에틸 인돌을 함유하는 항노화용 화장료 조성물
SG183983A1 (en) 2010-03-17 2012-10-30 Abbott Res Bv Anti-nerve growth factor (ngf) antibody compositions
ITRM20110574A1 (it) * 2011-11-02 2013-05-03 Sampo S R L Preparato topico per indurre la pigmentazione cutanea e per il trattamento di discromie cutanee e vitiligine.
AU2016326434A1 (en) * 2015-09-22 2018-03-29 Johnson & Johnson Consumer Inc. Devices and methods for enhancing the topical application of a benefit agent
KR20170049299A (ko) * 2015-10-28 2017-05-10 경상대학교산학협력단 성장인자와 사이토카인을 포함하는 조성물
CN112409471B (zh) * 2016-04-13 2022-07-29 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体
CN107973848B (zh) * 2017-12-28 2020-10-16 未名生物医药有限公司 一种从混合物中分离天然序列神经生长因子的方法

Also Published As

Publication number Publication date
JP2022508676A (ja) 2022-01-19
IL282064B (en) 2022-09-01
KR20210075098A (ko) 2021-06-22
CN112823039A (zh) 2021-05-18
US20210395305A1 (en) 2021-12-23
EA202190888A1 (ru) 2021-07-07
IL282064A (en) 2021-05-31
AU2019357261A1 (en) 2021-05-13
EP3863728A1 (en) 2021-08-18
BR112021006742A2 (pt) 2021-09-21
CA3115025A1 (en) 2020-04-16
WO2020075108A1 (en) 2020-04-16
IT201800009384A1 (it) 2020-04-11

Similar Documents

Publication Publication Date Title
IL282064A (en) Peptides for use in the treatment and prevention of skin aging and photoaging
HK1255488A1 (zh) 組合t細胞激活和/或檢查點抑制劑治療癌症的肽和肽模擬物
IL282871A (en) Systems and methods for skin treatment
EP3444265A4 (en) PEPTIDE FOR SKIN AGING OR WOUND TREATMENT AND USE THEREOF
PL3758730T3 (pl) Peptydy i kompozycje do stosowania w kosmetyce i medycynie
ZA202104737B (en) Methods and compositions for treating skin and hair disorders
IL257224B (en) Compounds and methods for treating hair and scalp
IL270978B (en) Grape skin for use in the treatment of dysbiosis
EP3875153A4 (en) COSMETIC PRODUCT FOR THE HAIR, AND HAIR TREATMENT METHOD USING THE SAME
GB2588994B (en) Combar for skin and hair treatment
IL275340A (en) Peptides and other active compounds to treat pain and increase pain sensitivity
IL276920A (en) Hair coloring compound and method
EP3412275A4 (en) PEPTIDE WITH SKIN-LIGHTING ACTIVITY AND USE THEREOF
EP3366694A4 (en) NOVEL PEPTIDE AND COSMETIC COMPOSITION FOR PREVENTING AGING OF SKIN OR FORMATION OF WRINKLES CONTAINING IT
IL281501A (en) Preparations and methods for the treatment of cellulite
EP3947418C0 (en) PEPTIDES AND THEIR USE
EP3875154A4 (en) HAIR COSMETIC AND HAIR TREATMENT METHOD USING THEREOF
SG11201802955VA (en) Peptides of use in the preventive and curative treatment of alopecia
GB201810635D0 (en) Peptides and cancer treatment
EP3288963A4 (en) Pink1 c-terminal domain polypeptide and methods using the same in cancer treatment
IL277689A (en) Application of short peptides extracted from PEDF in tendon healing
ZA201802772B (en) Hair treatment composition and method
IL313183A (en) Peptides and methods for use in the treatment of pain
PT3758730T (pt) Péptidos e composições para utilização em cosmética e medicina
IL259395B (en) Cosmetic composition for use in the treatment and prevention of acne-prone skin